BCM
IRWD icon

Bridgeway Capital Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bridgeway Capital Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.55M Sell
440,493
-55,500
-11% -$227K 0.03% 596
2025
Q4 		$1.67M Buy
495,993
+345,993
+231% +$899K 0.04% 585
2025
Q3 		$197K Buy
150,000
+75,000
+100% +$77.6K ﹤0.01% 1016
2025
Q2 		$53.8K Buy
75,000
+44,000
+142% +$34.5K ﹤0.01% 1132
2025
Q1 		$45.6K Hold
31,000
– – ﹤0.01% 1125
2024
Q4 		$137K Sell
31,000
-280,200
-90% -$1.14M ﹤0.01% 1066
2024
Q3 		$1.28M Hold
311,200
– – 0.03% 617
2024
Q2 		$2.03M Sell
311,200
-16,800
-5% -$119K 0.05% 509
2024
Q1 		$2.86M Buy
+328,000
New +$3.98M 0.06% 463

Other funds holding IRWD

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Bridgeway Capital Management's IRWD Position: Q1 2026 in Review

Bridgeway Capital Management reduced its Ironwood Pharmaceuticals (IRWD) stake by 11% in Q1 2026, selling an estimated $227K and leaving 440,493 shares worth $1.55M. The position accounts for 0.03% of the portfolio, ranked #596.

Bridgeway Capital Management first reported a position in IRWD in Q1 2024 and has held it in 9 quarters since. The position peaked at $2.86M in Q1 2024. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

  • Bridgeway Capital Management held 440,493 shares of Ironwood Pharmaceuticals worth $1.55M as of Q1 2026.
  • Bridgeway Capital Management sold 55,500 Ironwood Pharmaceuticals shares in Q1 2026, an estimated $227K.
  • Ironwood Pharmaceuticals made up 0.03% of Bridgeway Capital Management's portfolio in Q1 2026, its #596 holding.
  • Bridgeway Capital Management first reported a position in Ironwood Pharmaceuticals in Q1 2024 and has held it in 9 quarters since.
  • Bridgeway Capital Management's Ironwood Pharmaceuticals position peaked at $2.86M in Q1 2024.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on Bridgeway Capital Management's 13F filing for Q1 2026, filed 15 May 2026.